A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis

被引:18
作者
Clifton, Ian J. [1 ]
Fletcher, Louise A. [2 ]
Beggs, Clive B. [3 ]
Denton, Miles [4 ]
Peckham, Daniel G. [1 ]
机构
[1] St James Univ Hosp, Reg Cyst Fibrosis Unit, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Dept Civil Engn, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Bradford, Sch Engn Design & Technol, Bradford Infect Grp, Bradford BD7 1DP, W Yorkshire, England
[4] Leeds Gen Infirm, Dept Microbiol, Leeds, W Yorkshire, England
关键词
D O I
10.1186/1471-2180-8-105
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Cystic fibrosis (CF) is an inherited multi-system disorder characterised by chronic airway infection with pathogens such as Pseudomonas aeruginosa. Acquisition of P. aeruginosa by patients with CF is usually from the environment, but recent studies have demonstrated patient to patient transmission of certain epidemic strains, possibly via an airborne route. This study was designed to examine the survival of P. aeruginosa within artificially generated aerosols. Results: Survival was effected by the solution used for aerosol generation. Within the aerosols it was adversely affected by an increase in air temperature. Both epidemic and non-epidemic strains of P. aeruginosa were able to survive within the aerosols, but strains expressing a mucoid phenotype had a survival advantage. Conclusion: This would suggest that segregating individuals free of P. aeruginosa from those with chronic P. aeruginosa infection who are more likely to be infected with mucoid strains may help reduce the risk of cross-infection. Environmental factors also appear to influence bacterial survival. Warming and drying the air within clinical areas and avoidance of humidification devices may also be beneficial in reducing the risk of cross-infection.
引用
收藏
页数:10
相关论文
共 32 条
[1]   Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients [J].
Al-Aloul, M ;
Crawley, J ;
Winstanley, C ;
Hart, CA ;
Ledson, MJ ;
Walshaw, MJ .
THORAX, 2004, 59 (04) :334-336
[2]   NEW SAMPLER FOR THE COLLECTION, SIZING, AND ENUMERATION OF VIABLE AIRBORNE PARTICLES [J].
ANDERSEN, AA .
JOURNAL OF BACTERIOLOGY, 1958, 76 (05) :471-484
[3]   Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics [J].
Armstrong, D ;
Bell, S ;
Robinson, M ;
Bye, P ;
Rose, B ;
Harbour, C ;
Lee, C ;
Service, H ;
Nissen, M ;
Syrmis, M ;
Wainwright, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (05) :2266-2267
[4]   The airborne transmission of infection in hospital buildings: Fact or fiction? [J].
Beggs, CB .
INDOOR AND BUILT ENVIRONMENT, 2003, 12 (1-2) :9-18
[5]   RESERVOIRS OF PSEUDOMONAS IN AN INTENSIVE-CARE UNIT FOR NEWBORN-INFANTS - MECHANISMS OF CONTROL [J].
BROWN, DG ;
BAUBLIS, J .
JOURNAL OF PEDIATRICS, 1977, 90 (03) :453-457
[6]  
Crook B., 1995, P247
[7]   Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center [J].
Denton, M ;
Kerr, K ;
Mooney, L ;
Keer, V ;
Rajgopal, A ;
Brownlee, K ;
Arundel, P ;
Conway, S .
PEDIATRIC PULMONOLOGY, 2002, 34 (04) :257-261
[8]  
DORING G, 1991, ZBL HYG UMWELTMED, V191, P494
[9]  
Doring G, 1996, PEDIATR PULM, V21, P90, DOI 10.1002/(SICI)1099-0496(199602)21:2<90::AID-PPUL5>3.0.CO
[10]  
2-T